ARDEA BIOSCIENCES, INC.

ACTIVE

9390 Towne Centre Dr Ste 100, 加利福尼亚州圣迭戈县, California, United Stateswww.ardeabio.comSubsidiary107 employeesEstablished: 1994-01-01

Part of 阿斯利康

Clinical Trials

32 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1994

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

42.6%

Phase 2

10.3%

Phase 3

10.3%

Phase 4

1.5%

Trial Status Distribution

Active, not recruiting

47.1%

Completed

52.9%

Clinical Trials

Trials sponsored by this organization (68)

Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.

Phase 1

Completed

interventional

Aug 201732 participants

Page 1 of 9

Approvals

No approval data available

News

No news articles found

Back to Organizations

ARDEA BIOSCIENCES, INC.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (68)

Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.

Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence

RDEA3170 PK/PD Study

Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability

Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects

RDEA3170 Tablet and Capsule Bioavailability Study

IVIVR Assessing PK Parameters Used to Establish Bioequivalence

DECT Study in Allopurinol-Treated Gout Patients

Approvals

News